CSL Seqirus Shares Data Demonstrating the Potential for Influenza Vaccination to Reduce the Burden on Healthcare Resources

Contributed by: PR Newswire

Tags

CSL-Seqirus-Influenza

More Like This

UK Government Strengthens Vaccine Partnership with CSL Seqirus, Introducing World-First Flu vaccine (aTIVc) and Extending Health Security Pandemic Agreement

Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults

PR Newswire associated0

CSL announces rise in full year net profit

Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains

ACCESS Newswire logo

Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025

18,000 flu-related deaths in past 2 winters as jab uptake falls

PR Newswire associated0

Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine

Biotech company Eradivir is developing lead drug EV25 to treat influenza